SIZMAZ, S. Et Al. 2022. Comparison of intravitreal injections of Ranibizumab and Aflibercept in neovascular age related macular degeneration. CLINICAL AND EXPERIMENTAL OPTOMETRY , vol.105, no.1 , 55-60.

SIZMAZ, S., ESEN, E., Isik-Ericek, P., & Demircan, N., (2022). Comparison of intravitreal injections of Ranibizumab and Aflibercept in neovascular age related macular degeneration. CLINICAL AND EXPERIMENTAL OPTOMETRY , vol.105, no.1, 55-60.

SIZMAZ, SELÇUK Et Al. "Comparison of intravitreal injections of Ranibizumab and Aflibercept in neovascular age related macular degeneration," CLINICAL AND EXPERIMENTAL OPTOMETRY , vol.105, no.1, 55-60, 2022

SIZMAZ, SELÇUK Et Al. "Comparison of intravitreal injections of Ranibizumab and Aflibercept in neovascular age related macular degeneration." CLINICAL AND EXPERIMENTAL OPTOMETRY , vol.105, no.1, pp.55-60, 2022

SIZMAZ, S. Et Al. (2022) . "Comparison of intravitreal injections of Ranibizumab and Aflibercept in neovascular age related macular degeneration." CLINICAL AND EXPERIMENTAL OPTOMETRY , vol.105, no.1, pp.55-60.

@article{article, author={SELÇUK SIZMAZ Et Al. }, title={Comparison of intravitreal injections of Ranibizumab and Aflibercept in neovascular age related macular degeneration}, journal={CLINICAL AND EXPERIMENTAL OPTOMETRY}, year=2022, pages={55-60} }